Who invested in DecImmune Therapeutics?
DecImmune Therapeutics's investors include HealthCare Ventures, Astellas Venture Management, Amgen and Longview Ventures.
United States · Funded startup
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.4Mraised across 3 rounds since 2010, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
Reported by finsmes.comSEC filing: $1.7M sold, first sale Jan 2013
Reported by finsmes.comSEC filing: $1.1M sold, first sale Sept 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
DecImmune Therapeutics's investors include HealthCare Ventures, Astellas Venture Management, Amgen and Longview Ventures.
DecImmune Therapeutics has raised $8.4M across 3 rounds since 2010.
DecImmune Therapeutics's most recent round was a Grant of $3.0M in Oct 2014.
DecImmune Therapeutics's largest round on record is $3.2M (Venture), in Sept 2010.
DecImmune Therapeutics's first round on record, in Sept 2010, was backed by HealthCare Ventures, Amgen and Astellas Venture Management.
DecImmune Therapeutics's latest named round is a Grant, in Oct 2014.
DecImmune Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.